Home › Anal Cancer › NCT07192055
Self-sampling to Optimize Anal Lesion Outcomes
Self-sampling to Optimize Anal Lesion Outcomes (SOLO)
Who can join
Ages 35 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
A potential study subject who meets all of the following inclusion criteria is eligible to participate in the study. Note that these criteria apply regardless of HPV vaccination status or disability status. Inclusion Criteria: 1. Age ≥ 35 years for those who are HIV-positive or ≥ 45 years for those who are HIV-negative. 2. Must be either: 1. A cisgender or transgender sexual minority man, or 2. A transgender woman who has sex with men. 3. Resides in Chicago, Houston, or Milwaukee metropolitan area. 4. Is willing to attend a study clinic. 5. Speak and understand either English or Spanish 6. Ability to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: A potential study subject who meets any of the following exclusion criteria is ineligible to participate in the study. 1. Was a participant in the PAC Self-Swab Study in Milwaukee. 2. Currently on anticoagulants, with the exception of aspirin or non-steroidal anti-inflammatory drugs (NSAIDs), e.g., ibuprofen, naproxen. 3. Diagnosed with hemophilia, cirrhosis with bleeding varices, or thrombocytopenia. 4. Presence of any contraindicating severe disease or condition, e.g., anal stenosis. 5. Plans to move within 12 months after enrollment.
About the study
The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appointment attendance. Secondarily, the study will assess if a person who gets their choice of either self-sampling or healthcare provider sampling affects clinic attendance.
What is being tested
- Self-sampling (behavioral)
- Nylon-flocked Swab (other)
Sponsor: Medical College of Wisconsin · Participants: 572 · Started: Nov 18, 2025
Contact the study team
- Alan G Nyitray, PhD · Phone: 4149557701
- Jenna Nitkowski, PhD · Phone: 414-955-2126
Official record on ClinicalTrials.gov — NCT07192055
Locations in the U.S.
| Illinois | University of Chicago, Chicago |
| Texas | The University of Texas M.D. Anderson Cancer Center, Houston |
| Wisconsin | Medical College of Wisconsin, Milwaukee |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.